Past, present and future of pharmacovigilance in India

Systematic Reviews in Pharmacy

Volumn 2, Issue 1, 2011, Pages 55-58

  Kumar, A ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Adverse drug reaction; Central drugs standard control organization; Drug controller general of india pharmacovigilance; Uppsala monitoring centre; World Health Organization

Indexed keywords

DIETHYLENE GLYCOL; SULFANILAMIDE; THALIDOMIDE;

ADVERSE DRUG REACTION; COST EFFECTIVENESS ANALYSIS; DRUG FATALITY; DRUG INDUSTRY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HISTORY OF MEDICINE; HUMAN; INDIA; INFORMATION DISSEMINATION; MEDICAL INFORMATION; MORNING SICKNESS; NAUSEA; PHOCOMELIA; POPULATION RESEARCH; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; STREPTOCOCCUS INFECTION; TERATOGENICITY;

EID: 80051907640     PISSN: 09758453     EISSN: 09762779     Source Type: Journal    
DOI: 10.4103/0975-8453.83440     Document Type: Review

References (9)

1. WHO Definition of Pharmacovigilance. 2002
2. Manual for Good Bioavailability and Bioequivalence Practices. Vol. 1, Mod. 1. Clinical Phase. 1st ed. Brazil; 2002. p. 5-6. Available from: [Last accessed on 2010 Aug 25].
3. Kulkarni RD. Reporting system for rare side effects of non-narcotic analgesics in India: Problems and opportunities. Med Toxicol 1986;1:110-3. (Pubitemid 17013553)
4. Protocol for National Pharmacovigilance Program. CDSCO, Ministry of Health and Family Welfare, Government of India, 2004.
5. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA 1998;279:1200-5. (Pubitemid 28193431)
6. Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, et al. Adverse drug events in ambulatory care. N Engl J Med 2003;348:1556-64. (Pubitemid 36437933)
7. Nair MD. Pharmacovigilance: The need for a formal system in India. Available from: http://www.pharmabiz.com. [Last accessed on 2010 Aug 25].
8. The Erice declaration: On communicating drug safety information. Prescrire Int 1998;7:191.
9. Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Union 30 April 2004: L136/34-L 136/57.